Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Pain
|
September 15, 2004
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer
Jean-Jacques Body, Ingo J Diel, Richard Bell, et al.
American Journal of Obstetrics and Gynecology
|
April 4, 2007
Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy
Florian Schuetz, Ingo J Diel, Marit Pueschel, et al.
Critical Reviews in Oncology/Hematology
|
September 15, 2007
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Ingo J Diel, Ignac Fogelman, Bilal Al-Nawas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 17, 2018
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors
Camille N Abboud, Nicole Lang, Henry Fung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
Ingo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
International Journal of Cancer
|
April 25, 2003
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice
Philipp Beckhove, Florian Schütz, Ingo J Diel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 6, 2022
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Ingo J Diel, Richard Greil, Jan Janssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer
Gunter von Minckwitz, Volker Möbus, Andreas Schneeweiss, et al.
Oncology Research and Treatment
|
May 14, 2015
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
Christian M Kurbacher, Thomas Fietz, Ingo J Diel, et al.
The New England Journal of Medicine
|
August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun, Florian D Vogl, Bjørn Naume, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Pain
|
September 15, 2004
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer
Jean-Jacques Body, Ingo J Diel, Richard Bell, et al.
American Journal of Obstetrics and Gynecology
|
April 4, 2007
Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy
Florian Schuetz, Ingo J Diel, Marit Pueschel, et al.
Critical Reviews in Oncology/Hematology
|
September 15, 2007
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Ingo J Diel, Ignac Fogelman, Bilal Al-Nawas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 17, 2018
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors
Camille N Abboud, Nicole Lang, Henry Fung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
Ingo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
International Journal of Cancer
|
April 25, 2003
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice
Philipp Beckhove, Florian Schütz, Ingo J Diel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 6, 2022
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Ingo J Diel, Richard Greil, Jan Janssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer
Gunter von Minckwitz, Volker Möbus, Andreas Schneeweiss, et al.
Oncology Research and Treatment
|
May 14, 2015
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
Christian M Kurbacher, Thomas Fietz, Ingo J Diel, et al.
The New England Journal of Medicine
|
August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun, Florian D Vogl, Bjørn Naume, et al.
Page
of 2